New York 2023-2024 Regular Session

New York Assembly Bill A05914

Introduced
3/24/23  
Refer
3/24/23  

Caption

Designates Xylazine as a schedule III depressant.

Companion Bills

NY S05439

Same As Designates Xylazine as a schedule III depressant.

Previously Filed As

NY S05439

Designates Xylazine as a schedule III depressant.

NY S05421

Designates Xylazine as a schedule III depressant.

NY S07994

Adds home care visits to existing provisions of law prohibiting health care employers from requiring a nurse to work more than such nurse's regularly scheduled work hours, including regularly scheduled home care visits.

NY A08615

Adds home care visits to existing provisions of law prohibiting health care employers from requiring a nurse to work more than such nurse's regularly scheduled work hours, including regularly scheduled home care visits.

NY A5488

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances; requires reporting of xylazine prescriptions.

NY S191

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

NY A1526

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

NY SB2089

XYLAZINE-SCHEDULE I-PENALTIES

NY S3902

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

NY A5448

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

Similar Bills

No similar bills found.